Contract Win

Crimson Tide PLC
20 September 2023
 

20 September 2023

Crimson Tide plc

("Crimson Tide" or "the Company")

Contract Win in the United States

 

Crimson Tide Plc (TIDE) ("Crimson Tide" or "The Company"), the provider of the mpro5 solution, further extends its reach in the US by supporting a new client which provides catering services at UNC Health, part of the University of North Carolina (UNC).

 

Our client will use the mpro5 mobile app, reporting, and dashboards to ensure the timely delivery of meals at the appropriate temperature to students, initially on one of the medical campuses. mpro5 will also monitor and automate the dietary requirements of patients and use carb-counting to help regulate medicinal dosages for patients.

 

The mpro5 solution will help deliver over 240,000 warm, healthy, dietary-appropriate meals over this initial 3-year contract. The initial value of the contract is c$72,000, with the expectation that this will grow following the initial rollout.

 

The Company also announces that its nominated adviser and broker finnCap Ltd, has changed its name to Cavendish Capital Markets Limited.

 

Chairman Barrie Whipp commented, "This contract win extends our reach into the US, further emphasises our strength in the contract catering sector, and, most importantly, helps our client deliver safe and healthy meals to its most in-need patients. We look forward to exploring how we can further help US education providers meet the compliance, auditing and verification challenges of catering in a student environment."

 

 

Enquiries:

Crimson Tide plc +44 1892 542444

Barrie Whipp / Jacqueline Daniell

 

Cavendish Capital Markets (Nominated Adviser and Broker) +44 20 7220 0500

Julian Blunt / Milesh Hindocha, Corporate Finance

Andrew Burdis, Corporate Broking

 

Alma PR (Financial PR) +44 7780 901979

Josh Royston

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings